Back to Search Start Over

Is extensive cardio-pulmonary screening useful in athletes with previous asymptomatic or mild SARS-CoV-2 infection?

Authors :
Gervasi, Salvatore Francesco
Pengue, L
Damato, L
Monti, Riccardo
Pradella, S
Pirronti, Tommaso
Bartoloni, A
Epifani, F
Saggese, A
Cuccaro, F
Bianco, Massimiliano
Zeppilli, Paolo
Palmieri, Vincenzo
Gervasi SF
Monti R
Pirronti T (ORCID:0000-0003-3138-4097)
Bianco M (ORCID:0000-0002-0587-5899)
Zeppilli P (ORCID:0000-0002-5228-3634)
Palmieri V (ORCID:0000-0002-4478-4033)
Gervasi, Salvatore Francesco
Pengue, L
Damato, L
Monti, Riccardo
Pradella, S
Pirronti, Tommaso
Bartoloni, A
Epifani, F
Saggese, A
Cuccaro, F
Bianco, Massimiliano
Zeppilli, Paolo
Palmieri, Vincenzo
Gervasi SF
Monti R
Pirronti T (ORCID:0000-0003-3138-4097)
Bianco M (ORCID:0000-0002-0587-5899)
Zeppilli P (ORCID:0000-0002-5228-3634)
Palmieri V (ORCID:0000-0002-4478-4033)
Publication Year :
2021

Abstract

Objective During the COVID-19 pandemic, it is essential to understand if and how to screen SARSCoV-2-positive athletes to safely resume training and competitions. The aim of this study is to understand which investigations are useful in a screening protocol aimed at protecting health but also avoiding inappropriate examinations. Methods We conducted a cohort study of a professional soccer team that is based on an extensive screening protocol for resuming training during the COVID-19 pandemic. It included personal history, antigen swabs, blood tests, spirometry, resting/stress-test ECG with oxygen saturation monitoring, echocardiogram, Holter and chest CT. We also compared the findings with prior data from the same subjects before infection and with data from SARS-CoV-2-negative players. Results None of the players had positive swab and/ or anti-SARS-CoV-2 IgM class antibodies. Out of 30 players, 18 (60%) had IgG class antibodies. None had suffered severe SARS-CoV-2-related disease, 12 (66.7%) had complained of mild COVID-19-related symptoms and 6 (33.3%) were asymptomatic. None of the players we examined revealed significant cardiovascular abnormalities after clinical recovery. A mild reduction in spirometry parameters versus pre-COVID-19 values was observed in all athletes, but it was statistically significant (p<0.05) only in SARS-CoV-2-positive athletes. One SARS-CoV-2-positive player showed increased troponin I level, but extensive investigation did not show signs of myocardial damage. Conclusion In this small cohort of athletes with previous asymptomatic/mild SARS-CoV-2 infection, a comprehensive screening protocol including blood tests, spirometry, resting ECG, stress-test ECG with oxygen saturation monitoring and echocardiogram did not identify relevant anomalies. While larger studies are needed, extensive cardiorespiratory and haematological screening in athletes with asymptomatic/mild SARSCoV-2 infection appears unnecessary

Details

Database :
OAIster
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1256810376
Document Type :
Electronic Resource